Schedule 13G ownership disclosure
ELEDON PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 28617K101
Event date: 2024-10-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,566,338
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-114322
- Form type
- SC 13G
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Nov 05, 2024
- Reporting period
- Oct 29, 2024
- Description
- Schedule 13G beneficial ownership